Coagulation Made Simple

More documents

Recommendations

Info

Will my patient bleed? • Patients with liver disease, renal failure, obstructive jaundice, possibility of disseminated malignant disease Platelet count, aPTT, PT-INR (uremic patients usually have a vitamin-K deficiency) • Patients with uremia (qualitative platelet function abnormality) Bleeding time (improved with dialysis or administration of DDAVP)
Laboratory Monitoring of <strong>Coagulation</strong> • Prothrombin Time (PT-INR) – Plasma + Calcium + Tissue Thromboplastin TF + VIIa → Xa + V → IIa → CLOT • PT-INR only elevated – Factor VII deficiency • Congenital (very rare) • Acquired (Vit K deficiency, liver disease) – Factor VII inhibitor – Rarely in pts with modest decreases of factor V or X
Page 1 and 2: Coagulation Made Simple Thomas A. W
Page 3 and 4: Black Box View of Hemostasis Platel
Page 5 and 6: Vascular Injury Vasoconstriction Fi
Page 7 and 8: Coagulation Factors • I Fibrinoge
Page 9 and 10: “Classic” (Test Tube) Coagulati
Page 11 and 12: Factor VII - Tissue Factor “two-u
Page 13 and 14: Physiologic Anticoagulant Mechanism
Page 15 and 16: Will my patient bleed? • “Are y
Page 17 and 18: Inherited Defects of Platelet Funct
Page 19 and 20: Acquired or Inherited Factor Disord
Page 21 and 22: Von Willebrand Disease (vWD) • Pa
Page 23 and 24: Will my patient bleed? • Level II
Page 25: Will my patient bleed? • Level IV
Page 29 and 30: Laboratory Monitoring of Coagulatio
Page 31 and 32: Laboratory Monitoring of Coagulatio
Page 33 and 34: HEROIC AWARD TIME!! Save of the Mon
Page 35 and 36: Evaluation of Excessive Intraoperat
Page 41 and 42: FVIIa • Anticoagulant reversal ag
Page 43 and 44: Heparin- Induced Thrombocytopenia
Page 45 and 46: Anticoagulants Approved for Use by
Page 47: Black Box View of Hemostasis Platel

Coagulation Made Simple

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?